研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2021 年的期刊文章 · 第 24 页
共 1542 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2021-03-24 到 2021-03-08。
按期刊、按主题看 →
SiM Other · 发表于 2021-03-24
Christopher R. Bilder, Joshua M. Tebbs, Christopher S. McMahan
摘要
High‐volume testing of clinical specimens for sexually transmitted diseases is performed frequently by a process known as group testing. This algorithmic process involves testing portions of specimens from separate individuals together as one unit (or “group”) to detect diseases. Retesting is performed on groups that test positively in order to differentiate between positive and negative individual specimens. The overall goal is to use the least number of tests possible across all individuals without sacrificing diagnostic accuracy. One of the most efficient group testing algorithms is array testing. In its simplest form, specimens are arranged into a grid‐like structure so that row and column groups can be formed. Positive‐testing rows/columns indicate which specimens to retest. With the growing use of multiplex assays, the increasing number of diseases tested by these assays, and the availability of subject‐specific risk information, opportunities exist to make this testing process even more efficient. We propose specific specimen arrangements within an array that can reduce the number of retests needed when compared with other array testing algorithms. We examine how to calculate operating characteristics, including the expected number of tests and the SD for the number of tests, and then subsequently find a best arrangement. Our methods are illustrated for chlamydia and gonorrhea detection with the Aptima Combo 2 Assay. We also provide R functions to make our research accessible to laboratories.
SMMR Other · 发表于 2021-03-24
Marcos Matabuena, Alexander Petersen, Juan C Vidal, Francisco Gude
摘要
Biosensor data have the potential to improve disease control and detection. However, the analysis of these data under free-living conditions is not feasible with current statistical techniques. To address this challenge, we introduce a new functional representation of biosensor data, termed the glucodensity, together with a data analysis framework based on distances between them. The new data analysis procedure is illustrated through an application in diabetes with continuous-time glucose monitoring (CGM) data. In this domain, we show marked improvement with respect to state-of-the-art analysis methods. In particular, our findings demonstrate that (i) the glucodensity possesses an extraordinary clinical sensitivity to capture the typical biomarkers used in the standard clinical practice in diabetes; (ii) previous biomarkers cannot accurately predict glucodensity, so that the latter is a richer source of information and; (iii) the glucodensity is a natural generalization of the time in range metric, this being the gold standard in the handling of CGM data. Furthermore, the new method overcomes many of the drawbacks of time in range metrics and provides more in-depth insight into assessing glucose metabolism.
SiM Latent Variables & Mixtures Spatial & Time Series Networks & Graphs · 发表于 2021-03-24
Yei Eun Shin, Dawei Liu, Huiyan Sang, Toby A. Ferguson, Peter X. K. Song
摘要
Amyotrophic lateral sclerosis (ALS) is a neurological disease that starts at a focal point and gradually spreads to other parts of the nervous system. One of the main clinical symptoms of ALS is muscle weakness. To study spreading patterns of muscle weakness, we analyze spatiotemporal binary muscle strength data, which indicates whether observed muscle strengths are impaired or healthy. We propose a hidden Markov model‐based approach that assumes the observed disease status depends on two latent disease states. The model enables us to estimate the incidence rate of ALS disease and the probability of disease state transition. Specifically, the latter is modeled by a logistic autoregression in that the spatial network of susceptible muscles follows a Markov process. The proposed model is flexible to allow both historical muscle conditions and their spatial relationships to be included in the analysis. To estimate the model parameters, we provide an iterative algorithm to maximize sparse‐penalized likelihood with bias correction, and use the Viterbi algorithm to label hidden disease states. We apply the proposed approach to analyze the ALS patients' data from EMPOWER Study.
SMMR High-Dimensional Causal Inference · 发表于 2021-03-23
Zhaoxin Ye, Yeying Zhu, Donna L Coffman
摘要
Causal mediation effect estimates can be obtained from marginal structural models using inverse probability weighting with appropriate weights. In order to compute weights, treatment and mediator propensity score models need to be fitted first. If the covariates are high-dimensional, parsimonious propensity score models can be developed by regularization methods including LASSO and its variants. Furthermore, in a mediation setup, more efficient direct or indirect effect estimators can be obtained by using outcome-adaptive LASSO to select variables for propensity score models by incorporating the outcome information. A simulation study is conducted to assess how different regularization methods can affect the performance of estimated natural direct and indirect effect odds ratios. Our simulation results show that regularizing propensity score models by outcome-adaptive LASSO can improve the efficiency of the natural effect estimators and by optimizing balance in the covariates, bias can be reduced in most cases. The regularization methods are then applied to MIMIC-III database, an ICU database developed by MIT.
Biometrics Spatial & Time Series Latent Variables & Mixtures Bayesian Methods · 发表于 2021-03-23
Lu Zhang, Sudipto Banerjee
摘要
Multivariate spatially oriented data sets are prevalent in the environmental and physical sciences. Scientists seek to jointly model multiple variables, each indexed by a spatial location, to capture any underlying spatial association for each variable and associations among the different dependent variables. Multivariate latent spatial process models have proved effective in driving statistical inference and rendering better predictive inference at arbitrary locations for the spatial process. High‐dimensional multivariate spatial data, which are the theme of this article, refer to data sets where the number of spatial locations and the number of spatially dependent variables is very large. The field has witnessed substantial developments in scalable models for univariate spatial processes, but such methods for multivariate spatial processes, especially when the number of outcomes are moderately large, are limited in comparison. Here, we extend scalable modeling strategies for a single process to multivariate processes. We pursue Bayesian inference, which is attractive for full uncertainty quantification of the latent spatial process. Our approach exploits distribution theory for the matrix‐normal distribution, which we use to construct scalable versions of a hierarchical linear model of coregionalization (LMC) and spatial factor models that deliver inference over a high‐dimensional parameter space including the latent spatial process. We illustrate the computational and inferential benefits of our algorithms over competing methods using simulation studies and an analysis of a massive vegetation index data set.
Biometrics Survival Analysis Nonparametric & Semiparametric · 发表于 2021-03-23
Svetlana K. Eden, Chun Li, Bryan E. Shepherd
摘要
We study rank‐based approaches to estimate the correlation between two right‐censored variables. With end‐of‐study censoring, it is often impossible to nonparametrically identify the complete bivariate survival distribution, and therefore it is impossible to nonparametrically compute Spearman's rank correlation. As a solution, we propose two measures that can be nonparametrically estimated. The first measure is Spearman's correlation in a restricted region. The second measure is Spearman's correlation for an altered but estimable joint distribution. We describe population parameters for these measures and illustrate how they are similar to and different from the overall Spearman's correlation. We propose consistent estimators of these measures and study their performance through simulations. We illustrate our methods with a study assessing the correlation between the time to viral failure and the time to regimen change among persons living with HIV in Latin America who start antiretroviral therapy.
JASA Genetics & Omics Longitudinal Data · 发表于 2021-03-22
Kevin Z. Lin, Jing Lei, Kathryn Roeder
摘要
Scientists often embed cells into a lower-dimensional space when studying single-cell RNA-seq data for improved downstream analyses such as developmental trajectory analyses, but the statistical properties of such nonlinear embedding methods are often not well understood. In this article, we develop the exponential-family SVD (eSVD), a nonlinear embedding method for both cells and genes jointly with respect to a random dot product model using exponential-family distributions. Our estimator uses alternating minimization, which enables us to have a computationally efficient method, prove the identifiability conditions and consistency of our method, and provide statistically principled procedures to tune our method. All these qualities help advance the single-cell embedding literature, and we provide extensive simulations to demonstrate that the eSVD is competitive compared to other embedding methods. We apply the eSVD via Gaussian distributions where the standard deviations are proportional to the means to analyze a single-cell dataset of oligodendrocytes in mouse brains. Using the eSVD estimated embedding, we then investigate the cell developmental trajectories of the oligodendrocytes. While previous results are not able to distinguish the trajectories among the mature oligodendrocyte cell types, our diagnostics and results demonstrate there are two major developmental trajectories that diverge at mature oligodendrocytes. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplementary materials. *(abstract via PubMed)*
Biometrics Survival Analysis · 发表于 2021-03-22
Lior Rennert, Sharon X. Xie
摘要
Truncation is a statistical phenomenon that occurs in many time‐to‐event studies. For example, autopsy‐confirmed studies of neurodegenerative diseases are subject to an inherent left and right truncation, also known as double truncation. When the goal is to study the effect of risk factors on survival, the standard Cox regression model cannot be used when the survival time is subject to truncation. Existing methods that adjust for both left and right truncation in the Cox regression model require independence between the survival times and truncation times, which may not be a reasonable assumption in practice. We propose an expectation‐maximization algorithm to relax the independence assumption in the Cox regression model under left, right, or double truncation to an assumption of conditional independence on the observed covariates. The resulting regression coefficient estimators are consistent and asymptotically normal. We demonstrate through extensive simulations that the proposed estimator has little bias and has a similar or lower mean‐squared error compared to existing estimators. We implement our approach to assess the effect of occupation on survival in subjects with autopsy‐confirmed Alzheimer's disease.
SMMR Survival Analysis Nonparametric & Semiparametric · 发表于 2021-03-20
Lauren C Balmert, Ruosha Li, Limin Peng, Jong-Hyeon Jeong
摘要
The inactivity time, or lost lifespan specifically for mortality data, concerns time from occurrence of an event of interest to the current time point and has recently emerged as a new summary measure for cumulative information inherent in time-to-event data. This summary measure provides several benefits over the traditional methods, including more straightforward interpretation yet less sensitivity to heavy censoring. However, there exists no systematic modeling approach to inferring the quantile inactivity time in the literature. In this paper, we propose a semi-parametric regression method for the quantiles of the inactivity time distribution under right censoring. The consistency and asymptotic normality of the regression parameters are established. To avoid estimation of the probability density function of the inactivity time distribution under censoring, we propose a computationally efficient method for estimating the variance–covariance matrix of the regression coefficient estimates. Simulation results are presented to validate the finite sample properties of the proposed estimators and test statistics. The proposed method is illustrated with a real dataset from a clinical trial on breast cancer.
SMMR Causal Inference · 发表于 2021-03-20
Margarita Moreno-Betancur, Paul Moran, Denise Becker, George C Patton, John B Carlin
摘要
Many epidemiological questions concern potential interventions to alter the pathways presumed to mediate an association. For example, we consider a study that investigates the benefit of interventions in young adulthood for ameliorating the poorer mid-life psychosocial outcomes of adolescent self-harmers relative to their healthy peers. Two methodological challenges arise. First, mediation methods have hitherto mostly focused on the elusive task of discovering pathways, rather than on the evaluation of mediator interventions. Second, the complexity of such questions is invariably such that there are no well-defined mediator interventions (i.e. actual treatments, programs, etc.) for which data exist on the relevant populations, outcomes and time-spans of interest. Instead, researchers must rely on exposure (non-intervention) data, that is, on mediator measures such as depression symptoms for which the actual interventions that one might implement to alter them are not well defined. We propose a novel framework that addresses these challenges by defining mediation effects that map to a target trial of hypothetical interventions targeting multiple mediators for which we simulate the effects. Specifically, we specify a target trial addressing three policy-relevant questions, regarding the impacts of hypothetical interventions that would shift the mediators’ distributions (separately under various interdependence assumptions, jointly or sequentially) to user-specified distributions that can be emulated with the observed data. We then define novel interventional effects that map to this trial, simulating shifts by setting mediators to random draws from those distributions. We show that estimation using a g-computation method is possible under an expanded set of causal assumptions relative to inference with well-defined interventions, which reflects the lower level of evidence that is expected with ill-defined interventions. Application to the self-harm example in the Victorian Adolescent Health Cohort Study illustrates the value of our proposal for informing the design and evaluation of actual interventions in the future.
SiM Causal Inference High-Dimensional · 发表于 2021-03-19
Ruohong Li, Honglang Wang, Wanzhu Tu
摘要
Estimation of heterogeneous treatment effects is an essential component of precision medicine. Model and algorithm‐based methods have been developed within the causal inference framework to achieve valid estimation and inference. Existing methods such as the A‐learner, R‐learner, modified covariates method (with and without efficiency augmentation), inverse propensity score weighting, and augmented inverse propensity score weighting have been proposed mostly under the square error loss function. The performance of these methods in the presence of data irregularity and high dimensionality, such as that encountered in electronic health record (EHR) data analysis, has been less studied. In this research, we describe a general formulation that unifies many of the existing learners through a common score function. The new formulation allows the incorporation of least absolute deviation (LAD) regression and dimension reduction techniques to counter the challenges in EHR data analysis. We show that under a set of mild regularity conditions, the resultant estimator has an asymptotic normal distribution. Within this framework, we proposed two specific estimators for EHR analysis based on weighted LAD with penalties for sparsity and smoothness simultaneously. Our simulation studies show that the proposed methods are more robust to outliers under various circumstances. We use these methods to assess the blood pressure‐lowering effects of two commonly used antihypertensive therapies.
SiM Clinical Trials · 发表于 2021-03-18
Maximilian Pilz, Kevin Kunzmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
摘要
Adaptive designs are playing an increasingly important role in the planning of clinical trials. While there exists various research on the optimal determination of a two‐stage design, non‐optimal versions still are frequently applied in clinical research. In this article, we strive to motivate the application of optimal adaptive designs and give guidance on how to determine them. It is demonstrated that optimizing a trial design with respect to particular objective criteria can have a substantial benefit over the application of conventional adaptive sample size recalculation rules. Furthermore, we show that in many practical situations, optimal group‐sequential designs show an almost negligible performance loss compared to optimal adaptive designs. Finally, we illustrate how optimal designs can be tailored to specific operational requirements by customizing the underlying optimization problem.
SiM Clinical Trials · 发表于 2021-03-17
Xin Li, Wei Ma, Feifang Hu
摘要
Covariate‐adaptive randomization (CAR) procedures have been developed in clinical trials to mitigate the imbalance of treatments among covariates. In recent years, an increasing number of trials have started to use CAR for the advantages in statistical efficiency and enhancing credibility. At the same time, sample size re‐estimation (SSR) has become a common technique in industry to reduce time and cost while maintaining a good probability of success. Despite the widespread popularity of combining CAR designs with SSR, few researchers have investigated this combination theoretically. More importantly, the existing statistical inference must be adjusted to protect the desired type I error rate when a model that omits some covariates is used. In this article, we give a framework for the application of SSR in CAR trials and study the underlying theoretical properties. We give the adjusted test statistic and derive the sample size calculation formula under the CAR setting. We can tackle the difficulties caused by the adaptive features in CAR and prove the asymptotic independence between stages. Numerical studies are conducted under multiple parameter settings and scenarios that are commonly encountered in practice. The results show that all advantages of CAR and SSR can be preserved and further improved in terms of power and sample size.
Biometrika Causal Inference Networks & Graphs · 发表于 2021-03-17
E Smucler, F Sapienza, A Rotnitzky
摘要
Summary: We study the selection of adjustment sets for estimating the interventional mean under a point exposure dynamic treatment regime, that is, a treatment rule that depends on the subject’s covariates. We assume a nonparametric causal graphical model with, possibly, hidden variables and at least one adjustment set comprised of observable variables. We provide the definition of a valid adjustment set for a point exposure dynamic treatment regime, which generalizes the existing definition for a static intervention. We show that there exists an adjustment set, referred to as optimal minimal, that yields the nonparametric estimator of the interventional mean with the smallest asymptotic variance among those that are based on observable minimal adjustment sets. An observable minimal adjustment set is a valid adjustment set such that all its variables are observable and the removal of any of its variables destroys its validity. We provide similar optimality results for the class of observable minimum adjustment sets, that is, valid observable adjustment sets of minimum cardinality among the observable adjustment sets. Moreover, we show that if either no variables are hidden or if all the observable variables are ancestors of either treatment, outcome or the variables that are used to decide treatment, a globally optimal adjustment set exists. We provide polynomial-time algorithms to compute the globally optimal, optimal minimal and optimal minimum adjustment sets. Because static interventions can be viewed as a special case of dynamic regimes, all our results also apply for static interventions.
SiM Bayesian Methods Clinical Trials · 发表于 2021-03-17
Duncan T. Wilson, James M. S. Wason, Julia Brown, Amanda J. Farrin, Rebecca E. A. Walwyn
摘要
External pilot trials of complex interventions are used to help determine if and how a confirmatory trial should be undertaken, providing estimates of parameters such as recruitment, retention, and adherence rates. The decision to progress to the confirmatory trial is typically made by comparing these estimates to pre‐specified thresholds known as progression criteria, although the statistical properties of such decision rules are rarely assessed. Such assessment is complicated by several methodological challenges, including the simultaneous evaluation of multiple endpoints, complex multi‐level models, small sample sizes, and uncertainty in nuisance parameters. In response to these challenges, we describe a Bayesian approach to the design and analysis of external pilot trials. We show how progression decisions can be made by minimizing the expected value of a loss function, defined over the whole parameter space to allow for preferences and trade‐offs between multiple parameters to be articulated and used in the decision‐making process. The assessment of preferences is kept feasible by using a piecewise constant parametrization of the loss function, the parameters of which are chosen at the design stage to lead to desirable operating characteristics. We describe a flexible, yet computationally intensive, nested Monte Carlo algorithm for estimating operating characteristics. The method is used to revisit the design of an external pilot trial of a complex intervention designed to increase the physical activity of care home residents.
Biometrics Testing & Uncertainty · 发表于 2021-03-16
Frank Schaarschmidt, Christian Ritz, Ludwig A. Hothorn
摘要
In dose–response analysis, it is a challenge to choose appropriate linear or curvilinear shapes when considering multiple, differently scaled endpoints. It has been proposed to fit several marginal regression models that try sets of different transformations of the dose levels as explanatory variables for each endpoint. However, the multiple testing problem underlying this approach, involving correlated parameter estimates for the dose effect between and within endpoints, could only be adjusted heuristically. An asymptotic correction for multiple testing can be derived from the score functions of the marginal regression models. Based on a multivariate t ‐distribution, the correction provides a one‐step adjustment of p ‐values that accounts for the correlation between estimates from different marginal models. The advantages of the proposed methodology are demonstrated through three example datasets, involving generalized linear models with differently scaled endpoints, differing covariates, and a mixed effect model and through simulation results. The methodology is implemented in an R package.
JASA Nonparametric & Semiparametric · 发表于 2021-03-16
Kristian Bjørn Hessellund, Ganggang Xu, Yongtao Guan, Rasmus Waagepetersen
摘要
We propose a new method for analysis of multivariate point pattern data observed in a heterogeneous environment and with complex intensity functions. We suggest semiparametric models for the intensity functions that depend on an unspecified factor common to all types of points. This is for example well suited for analyzing spatial covariate effects on events such as street crime activities that occur in a complex urban environment. A multinomial conditional composite likelihood function is introduced for estimation of intensity function regression parameters and the asymptotic joint distribution of the resulting estimators is derived under mild conditions. Crucially, the asymptotic covariance matrix depends on ratios of cross pair correlation functions of the multivariate point process. To make valid statistical inference without restrictive assumptions, we construct consistent nonparametric estimators for these ratios. Finally, we construct standardized residual plots, predictive probability plots, and semiparametric intensity plots to validate and to visualize the findings of the model. The effectiveness of the proposed methodology is demonstrated through extensive simulation studies and an application to analyzing the effects of socio-economic and demographical variables on occurrences of street crimes in Washington DC. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction Missing Data & Measurement Error Clinical Trials · 发表于 2021-03-16
Susan Halabi, Chen‐Yen Lin, Aiyi Liu
摘要
A major emphasis in precision medicine is to optimally treat subgroups of patients who may benefit from certain therapeutic agents. And as such, enormous resources and innovative clinical trials designs in oncology are devoted to identifying predictive biomarkers. Predictive biomarkers are ones that will identify patients that are more likely to respond to specific therapies and they are usually discovered through retrospective analysis from large randomized phase II or phase III trials. One important design to consider is the stratified biomarker design, where patients will have their specimens obtained at baseline and the biomarker status will be assessed prior to random assignment. Regardless of their biomarker status, patients will be randomized to either an experimental arm or the standard of care arm. The stratified biomarker design can be used to test for a treatment‐biomarker interaction in predicting a time‐to event outcome. Many biomarkers, however, are derived from tissues from patients, and their levels may be heterogeneous. As a result, biomarker levels may be measured with error and this would have an adverse impact on the power of a stratified biomarker clinical trial. We present a trial design and an analysis framework for the stratified biomarker design. We show that the naïve test is biased and provide bias‐corrected estimators for computing the sample size and the 95% confidence interval when testing for a treatment‐biomarker interaction in predicting a time to event outcome. We propose a sample size formula that adjusts for misclassification and apply it in the design of a phase III clinical trial in renal cancer.
JASA Networks & Graphs Missing Data & Measurement Error · 发表于 2021-03-16
Karthika Mohan, Judea Pearl
摘要
This article reviews recent advances in missing data research using graphical models to represent multivariate dependencies. We first examine the limitations of traditional frameworks from three different perspectives: transparency, estimability, and testability. We then show how procedures based on graphical models can overcome these limitations and provide meaningful performance guarantees even when data are missing not at random (MNAR). In particular, we identify conditions that guarantee consistent estimation in broad categories of missing data problems, and derive procedures for implementing this estimation. Finally, we derive testable implications for missing data models in both missing at random and MNAR categories. *(abstract via OpenAlex)*
SiM Bayesian Methods · 发表于 2021-03-16
Melissa Jay, Jacob Oleson, Mary Charlton, Ali Arab
摘要
Age‐adjusted rates are frequently used by epidemiologists to compare disease incidence and mortality across populations. In small geographic regions, age‐adjusted rates computed directly from the data are subject to considerable variability and are generally unreliable. Therefore, we desire an approach that accounts for the excessive number of zero counts in disease mapping datasets, which are naturally present for low‐prevalence diseases and are further innated when stratifying by age group. Bayesian modeling approaches are naturally suited to employ spatial and temporal smoothing to produce more stable estimates of age‐adjusted rates for small areas. We propose a Bayesian hierarchical spatio‐temporal hurdle model for counts and demonstrate how age‐adjusted rates can be estimated from the hurdle model. We perform a simulation study to evaluate the performance of the proposed model vs a traditional Poisson model on datasets with varying characteristics. The approach is illustrated using two applications to cancer mortality at the county level.
Biometrics High-Dimensional Latent Variables & Mixtures · 发表于 2021-03-15
Yujia Li, Xiangrui Zeng, Chien‐Wei Lin, George C. Tseng
摘要
Estimating the number of clusters (K) is a critical and often difficult task in cluster analysis. Many methods have been proposed to estimate K, including some top performers using resampling approach. When performing cluster analysis in high‐dimensional data, simultaneous clustering and feature selection is needed for improved interpretation and performance. To our knowledge, little has been studied for simultaneous estimation of K and feature sparsity parameter in a high‐dimensional exploratory cluster analysis. In this paper, we propose a resampling method to bridge this gap and evaluate its performance under the sparse K‐means clustering framework. The proposed target function balances between sensitivity and specificity of clustering evaluation of pairwise subjects from clustering of full and subsampled data. Through extensive simulations, the method performs among the best over classical methods in estimating K in low‐dimensional data. For high‐dimensional simulation data, it also shows superior performance to simultaneously estimate K and feature sparsity parameter. Finally, we evaluated the methods in four microarray, two RNA‐seq, one SNP, and two nonomics datasets. The proposed method achieves better clustering accuracy with fewer selected predictive genes in almost all real applications.
SiM Clinical Trials Causal Inference · 发表于 2021-03-15
Wen Li, Xiaofei Bai, Qiqi Deng, Fang Liu, Cong Chen
摘要
The 2‐in‐1 adaptive design allows seamless expansion of an ongoing Phase II trial into a Phase III trial to expedite a drug development program. Since its publication, it has generated a lot of interest. So far, most of the related research focused on type I error control. Similar to most adaptive designs, 2‐in‐1 design could also pose a great challenge on estimation of treatment effect due to the data‐driven adaptation. In addition, the use of intermediate endpoint for interim adaptive decision‐making is a less well‐studied field. In this paper, we investigate the bias and variances in estimation for 2‐in‐1 design and some of its extensions, and propose some bias‐adjusted estimators for 2‐in‐1 design. The properties of the proposed estimators are further studied theoretically and/or numerically, so as to provide guidance on how to interpret the estimated treatment effect of 2‐in‐1 design.
SiM Survival Analysis Bayesian Methods · 发表于 2021-03-13
Danilo Alvares, Elena Lázaro, Virgilio Gómez‐Rubio, Carmen Armero
摘要
Survival analysis is one of the most important fields of statistics in medicine and biological sciences. In addition, the computational advances in the last decades have favored the use of Bayesian methods in this context, providing a flexible and powerful alternative to the traditional frequentist approach. The objective of this article is to summarize some of the most popular Bayesian survival models, such as accelerated failure time, proportional hazards, mixture cure, competing risks, multi‐state, frailty, and joint models of longitudinal and survival data. Moreover, an implementation of each presented model is provided using a BUGS syntax that can be run with JAGS from the R programming language. Reference to other Bayesian R‐packages is also discussed.
Biometrika Other · 发表于 2021-03-12
Joseph Guinness
摘要
Summary: We conduct a study of the aliased spectral densities of Matérn covariance functions on a regular grid of points, elucidating the properties of a popular approximation based on stochastic partial differential equations. While other researchers have shown that this approximation can work well for the covariance function, we find that it assigns too much power at high frequencies and does not provide increasingly accurate approximations to the inverse as the grid spacing goes to zero, except in the one-dimensional exponential covariance case.
Biometrika Causal Inference Latent Variables & Mixtures · 发表于 2021-03-12
Dehan Kong, Shu Yang, Linbo Wang
摘要
Summary: Unobserved confounding presents a major threat to causal inference in observational studies. Recently, several authors have suggested that this problem could be overcome in a shared confounding setting where multiple treatments are independent given a common latent confounder. It has been shown that under a linear Gaussian model for the treatments, the causal effect is not identifiable without parametric assumptions on the outcome model. In this note, we show that the causal effect is indeed identifiable if we assume a general binary choice model for the outcome with a non-probit link. Our identification approach is based on the incongruence between Gaussianity of the treatments and latent confounder and non-Gaussianity of a latent outcome variable. We further develop a two-step likelihood-based estimation procedure.
SiM Other · 发表于 2021-03-10
Pei Wang, Erin L. Abner, David W. Fardo, Frederick A. Schmitt, Gregory A. Jicha, Linda J. Van Eldik, Richard J. Kryscio
摘要
Finite Markov chains are useful tools for studying transitions among health states; these chains can be complex consisting of a mix of transient and absorbing states. The transition probabilities, which are often affected by covariates, can be difficult to estimate due to the presence of many covariates and/or a subset of transitions that are rarely observed. The purpose of this article is to show how to estimate the effect of a subset of covariates of interest after adjusting for the presence of multiple other covariates by applying multidimensional dimension reduction to the latter. The case in which transitions within each row of the one‐step transition probability matrix are estimated by multinomial logistic regression is discussed in detail. Dimension reduction for the adjustment covariates involves estimating the effect of the covariates by a product of matrices iteratively; at each iteration one matrix in the product is fixed while the second is estimated using either standard software or nonlinear estimation, depending on which of the matrices in the product is fixed. The algorithm is illustrated by an application where the effect of at least one Apolipoprotein‐E (APOE) gene allele on transition probability is estimated in a Markov Chain that includes adjustment for eight covariates and focuses on transitions from normal cognition to several forms of mild cognitive impairment, with possible absorption into dementia. Data were drawn from annual cognitive assessments of 649 participants enrolled in the BRAiNS cohort at the University of Kentucky's Alzheimer's Disease Research Center.
SMMR Bayesian Methods · 发表于 2021-03-10
Kim May Lee, J Jack Lee
摘要
Bayesian adaptive randomization is a heuristic approach that aims to randomize more patients to the putatively superior arms based on the trend of the accrued data in a trial. Many statistical aspects of this approach have been explored and compared with other approaches; yet only a limited number of works has focused on improving its performance and providing guidance on its application to real trials. An undesirable property of this approach is that the procedure would randomize patients to an inferior arm in some circumstances, which has raised concerns in its application. Here, we propose an adaptive clip method to rectify the problem by incorporating a data-driven function to be used in conjunction with Bayesian adaptive randomization procedure. This function aims to minimize the chance of assigning patients to inferior arms during the early time of the trial. Moreover, we propose a utility approach to facilitate the selection of a randomization procedure. A cost that reflects the penalty of assigning patients to the inferior arm(s) in the trial is incorporated into our utility function along with all patients benefited from the trial, both within and beyond the trial. We illustrate the selection strategy for a wide range of scenarios.
SiM Survival Analysis Clinical Trials Testing & Uncertainty · 发表于 2021-03-09
Rosamarie Frieri, Maroussa Zagoraiou
摘要
Multi‐arm clinical trials are complex experiments which involve several objectives. The demand for unequal allocations in a multi‐treatment context is growing and adaptive designs are being increasingly used in several areas of medical research. For uncensored and censored exponential responses, we propose a constrained optimization approach in order to derive the design maximizing the power of the multivariate test of homogeneity, under a suitable ethical constraint. In the absence of censoring, we obtain a very simple closed‐form solution that dominates the balanced design in terms of power and ethics. Our suggestion can also accommodate delayed responses and staggered entries, and can be implemented via response adaptive rules. While other targets proposed in the literature could present an unethical behavior, the suggested optimal allocation is frequently unbalanced by assigning more patients to the best treatment, both in the absence and presence of censoring. We evaluate the operating characteristics of our proposal theoretically and by simulations, also redesigning a real lung cancer trial, showing that the constrained optimal target guarantees very good performances in terms of ethical demands, power and estimation precision. Therefore, it is a valid and useful tool in designing clinical trials, especially oncological trials and clinical experiments for grave and novel infectious diseases, where the ethical concern is of primary importance.
SiM Longitudinal Data Bayesian Methods Clinical Trials · 发表于 2021-03-09
Charles Spanbauer, Rodney Sparapani
摘要
Precision medicine is an active area of research that could offer an analytic paradigm shift for clinical trials and the subsequent treatment decisions based on them. Clinical trials are typically analyzed with the intent of discovering beneficial treatments if the same treatment is applied to the entire population under study. But, such a treatment strategy could be suboptimal if subsets of the population exhibit varying treatment effects. Identifying subsets of the population experiencing differential treatment effect and forming individualized treatment rules is a task well‐suited to modern machine learning methods such as tree‐based ensemble predictive models. Specifically, Bayesian additive regression trees (BART) has shown promise in this regard because of its exceptional performance in out‐of‐sample prediction. Due to the unique inferential needs of precision medicine for clinical trials, we have proposed the BART extensions explicated here. We incorporate random effects for longitudinal repeated measures and subject clustering within medical centers. The addition of a novel interaction detection prior to identify treatment heterogeneity among clinical trial patients and its association with patient characteristics. These extensions are unified under a framework that we call mixedBART. Simulation studies and applications of precision medicine based on real randomized clinical trials data examples are presented.
JASA Causal Inference Econometrics & Economics · 发表于 2021-03-09
Yifan Cui, Eric Tchetgen Tchetgen
摘要
This JASA rejoinder concerns the problem of individualized decision making under point, sign, and partial identification. The paper unifies various classical decision making strategies through a lower bound perspective proposed in Cui and Tchetgen Tchetgen (2020b) in the context of optimal treatment regimes under uncertainty due to unmeasured confounding. Building on this unified framework, the paper also provides a novel minimax solution (i.e., a rule that minimizes the maximum regret for so-called opportunists) for individualized decision making/policy assignment. *(abstract via PubMed)*
SiM Causal Inference Latent Variables & Mixtures · 发表于 2021-03-09
Kyaw Sint, Robert Rosenheck, Haiqun Lin
摘要
This paper demonstrates the utility of latent classes in evaluating the effect of an intervention on an outcome through multiple indicators of mediation. These indicators are observed intermediate variables that identify an underlying latent class mediator, with each class representing a different mediating pathway. The use of a latent class mediator allows us to avoid modeling the complex interactions between the multiple indicators and ensures the decomposition of the total mediating effects into additive effects from individual mediating pathways, a desirable feature for evaluating multiple indicators of mediation. This method is suitable when the goal is to estimate the total mediating effects that can be decomposed into the additive effects of distinct mediating pathways. Each indicator may be involved in multiple mediation pathways and at the same time multiple indicators may contribute to a single mediating pathway. The relative importance of each pathway may vary across subjects. We applied this method to the analysis of the first 6 months of data from a 2‐year clustered randomized trial for adults in their first episode of schizophrenia. Four indicators of mediation are considered: individual resiliency training; family psychoeducation; supported education and employment; and a structural assessment for medication. The improvement in symptoms was found to be mediated by the latent class mediator derived from these four service indicators. Simulation studies were conducted to assess the performance of the proposed model and showed that the simultaneous estimation through the maximum likelihood yielded little bias when the entropy of the indicators was high.
JASA Other · 发表于 2021-03-09
Michael R. Kosorok, Eric B. Laber, Dylan S. Small, Donglin Zeng
摘要
We introduce the Theory and Methods Special Issue on Precision Medicine and Individualized Policy Discovery. The issue consists of four discussion papers, grouped into two pairs, and sixteen regular research papers that cover many important lines of research on data-driven decision making. We hope that the many provocative and original ideas presented herein will inspire further work and development in precision medicine and personalization. *(abstract via OpenAlex)*
JASA Spatial & Time Series · 发表于 2021-03-09
Paula Moraga
摘要
The Handbook of Spatial Epidemiology is an edited anthology of chapters written by experts in the field that cover a wide range of methods used to understand the geographic and temporal patterns of... *(abstract via OpenAlex)*
JASA Causal Inference High-Dimensional Nonparametric & Semiparametric · 发表于 2021-03-09
Wenchuan Guo, Xiao-Hua Zhou, Shujie Ma
摘要
With a large number of baseline covariates, we propose a new semiparametric modeling strategy for heterogeneous treatment effect estimation and individualized treatment selection, which are two major goals in personalized medicine. We achieve the first goal through estimating a covariate-specific treatment effect (CSTE) curve modeled as an unknown function of a weighted linear combination of all baseline covariates. The weight or the coefficient for each covariate is estimated by fitting a sparse semiparametric logistic single-index coefficient model. The CSTE curve is estimated by a spline-backfitted kernel procedure, which enables us to further construct a simultaneous confidence band (SCB) for the CSTE curve under a desired confidence level. Based on the SCB, we find the subgroups of patients that benefit from each treatment, so that we can make individualized treatment selection. The innovations of the proposed method are 3-fold. First, the proposed method can quantify variability associated with the estimated optimal individualized treatment rule with high-dimensional covariates. Second, the proposed method is very flexible to depict both local and global associations between the treatment and baseline covariates in the presence of high-dimensional covariates, and thus it enjoys flexibility while achieving dimensionality reduction. Third, the SCB achieves the nominal confidence level asymptotically, and it provides a uniform inferential tool in making individualized treatment decisions. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Diagnostics & Prediction · 发表于 2021-03-09
Siamak Sabour, Hadis Ghajari
SiM Survival Analysis Functional Data · 发表于 2021-03-09
Ewa Strzalkowska‐Kominiak, Juan Romo
摘要
Functional data analysis plays an increasingly important role in medical research because patients are followed over time. Thus, the measurements of a particular biomarker for each patient are often registered as curves. Hence, it is of interest to estimate the mean function under certain conditions as an average of the observed functional data over a given period. However, this is often difficult as this type of follow‐up studies are confronted with the challenge of some individuals dropping‐out before study completion. Therefore, for these individuals, only a partial functional observation is available. In this study, we propose an estimator for the functional mean when the functions may be censored from the right, and thus, only partly observed. Unlike sparse functional data, the censored curves are observed until some (random) time and this censoring time may depend on the trajectory of the functional observations. Our approach is model‐free and fully nonparametric, although the proposed methods can also be incorporated into regression models. The use of the functional structure of the data distinguishes our approach from the longitudinal data approaches. In addition, in this study, we propose a bootstrap‐based confidence band for the mean function, examine the estimation of the covariance function, and apply our new approach to functional principal component analysis. Employing an extensive simulation study, we demonstrate that our method outperforms the only two existing approaches. Furthermore, we apply our new estimator to a real data example on lung growth, measured by changes in pulmonary function for girls in the United States.
JASA Other · 发表于 2021-03-08
Abdelaati Daouia, Irène Gijbels, Gilles Stupfler
摘要
Regression extremiles define a least squares analogue of regression quantiles. They are determined by weighted expectations rather than tail probabilities. Of special interest is their intuitive meaning in terms of expected minima and maxima. Their use appears naturally in risk management where, in contrast to quantiles, they fulfill the coherency axiom and take the severity of tail losses into account. In addition, they are comonotonically additive and belong to both the families of spectral risk measures and concave distortion risk measures. This article provides the first detailed study exploring implications of the extremile terminology in a general setting of presence of covariates. We rely on local linear (least squares) check function minimization for estimating conditional extremiles and deriving the asymptotic normality of their estimators. We also extend extremile regression far into the tails of heavy-tailed distributions. Extrapolated estimators are constructed and their asymptotic theory is developed. Some applications to real data are provided. *(abstract via OpenAlex)*